Showing results (191-200 of 529) with videos related to
Sort By:
Pageof 53
Schizophrenia (Heidelberg, Germany)|November 15, 2024
Meta-analyses of epigenetic age acceleration and GrimAge components of schizophrenia or first-episode psychosisToshiyuki Shirai, Satoshi Okazaki, Takaki Tanifuji, et al.Schizophrenia (Heidelberg, Germany)|November 2, 2024
Brain structural associations of syntactic complexity and diversity across schizophrenia spectrum and major depressive disorders, and healthy controlsKatharina Schneider, Nina Alexander, Andreas Jansen, et al.Schizophrenia (Heidelberg, Germany)|October 31, 2024
Multisensory temporal processing in schizophrenia and bipolar disorder: implications for psychosisMaria Bianca Amadeo, Andrea Escelsior, Davide Esposito, et al.Schizophrenia (Heidelberg, Germany)|November 28, 2024
FMR1 genetically interacts with DISC1 to regulate glutamatergic synaptogenesisTakato Honda, Kazuki Kurita, Yuko Arai, et al.Schizophrenia (Heidelberg, Germany)|March 11, 2025
Association between white blood cell counts and the efficacy on cognitive function after rTMS intervention in schizophreniaSuzhen Ye, Bailing Wang, Heling Sui, et al.Schizophrenia (Heidelberg, Germany)|March 8, 2025
Characterization of cardiac autonomic dysfunction in acute Schizophrenia: a cluster analysis of heart rate variability parametersAlexander Refisch, Andy Schumann, Yubraj Gupta, et al.Schizophrenia (Heidelberg, Germany)|October 27, 2024
Enhancing visual working memory in schizophrenia: effects of frontoparietal theta tACS in low-performing patientsJiunn-Kae Wang, Prangya Parimita Sahu, Hsiao-Lun Ku, et al.Schizophrenia (Heidelberg, Germany)|October 4, 2024
A generalisability theory approach to quantifying changes in psychopathology among ultra-high-risk individuals for psychosisZohreh Doborjeh, Oleg N Medvedev, Maryam Doborjeh, et al.Schizophrenia (Heidelberg, Germany)|August 22, 2024
Long-term clinical recovery and treatment resistance in first-episode psychosis: a 10-year follow-up studyKristin Fjelnseth Wold, Isabel Viola Kreis, Gina Åsbø, et al.Schizophrenia (Heidelberg, Germany)|July 17, 2024
Exploration on the potential efficacy and mechanism of methyl salicylate glycosides in the treatment of schizophrenia based on bioinformatics, molecular docking and dynamics simulationXiuhuan Wang, Jiamu Ma, Ying Dong, et al.Pageof 53